Antibody Testing
Get clear and easy to interpret results, with our antibody detection products including HLA screening, identification, single antigen, and Non-HLA antibody kits.
LIFECODES® LifeScreen XP and LIFECODES® LifeScreen Deluxe
LIFECODES LifeScreen XP is the newest addition to the Werfen HLA Antibody assessment portfolio. With seven beads for Class I and seven beads for Class II, including new beads specific for the detection of HLA-DP. LifeScreen XP gives you a comprehensive tool for screening and monitoring of HLA antibodies.
LIFECODES® Class I and Class II ID
The LIFECODES HLA Antibody Detection System utilizes Luminex® xMAP® technology to achieve flow cytometric sensitivity.LIFECODES Class I and II ID panels provide antibody identification and panel-reactive antibody (PRA) information.
LIFECODES® LSA-MIC Assay
LSA-MIC kit is designed to detect antibodies directed against MICA antigens. Publications have suggested that anti-MICA antibodies may play a role in the failure of renal allografts.
LIFECODES® C3d Detection Assay
The LIFECODES C3d Assay provides a measure of the binding and processing of complement to one of its end products – C3d. When combined with our LIFECODES LSA Single Antigen Kits, the assay offers a simple method for the detection of complement binding to HLA antibodies.
LIFECODES® Non-HLA Antibody Assay
LIFECODES offers the complete antibody product portfolio for the transplant laboratory, including kits designed to detect and identify non-HLA antibodies in serum.
MATCH IT!® Antibody Analysis Software
MATCH IT! Antibody, a software designed specifically to simplify the complexities of HLA Antibody analysis.
LIFECODES® Donor Specific Antibody Assay
The DSA assay makes it possible to screen for the presence of antibodies directed against the HLA antigens of the donor. It is ideal for pre- and post-transplant testing.
lifecodesWHITE-LSA
The new, enhanced LSA Assays deliver increased coverage, optimized performance, and improve the overall workflow of the LIFECODES® HLA Antibody Analysis portfolio.